Despite recent advances in the derivation of rat embryonic stem cells, clear comprehension of the timing and mechanisms underlying rat early embryo lineage selection is lacking. We have previously shown the in vivo contribution of rat embryonic stem-like cells exclusively to developing extraembryonic tissues. To elucidate possible mechanisms governing the in vitro and in vivo behaviors of these rat blastocyst-derived stem cells, we evaluated their developmental capacity by using several approaches. Molecular marker analysis demonstrated the expression profile of genes characterizing not only pluripotency but also extraembryonic endoderm and trophoblast. In vitro differentiation through embryoid body formation showed in vitro pluripotent capacity through differentiation into derivatives of all three embryonic germ layers. Following either blastocyst injection, diploid or tetraploid aggregation, and embryo transfer, these rat blastocyst-derived stem cells also demonstrated in vivo multipotency through contribution to multiple developmentally distinct extraembryonic lineages. Features of phenotypic heterogeneity were revealed following examination of cell line morphology and culture behavior, as well as quantitative analysis of marker expression in discrete undifferentiated and differentiated populations of cells by flow cytometry. We demonstrate for the first time that stem cells derived from the rat blastocyst have the ability to contribute to the embryonic and extraembryonic lineages. Together, these results provide a valuable new model for rat stem cell biology and for the elucidation of early lineage selection in the embryo. cell lineage, early development, embryo, embryonic development, embryonic stem cells, epiblast, extraembryonic endoderm, heterogeneity, rats, trophoblast
INTRODUCTION
The development and application of gene-targeting technology using embryonic stem (ES) cells in the rat has been long awaited, not only because the larger size of this species simplifies manipulation and repeated sampling, but because the rat is the model of choice for an important number of biomedical research fields [1] [2] [3] . Due to the extensive information currently available on the rat and its physiology [4, 5] , the analysis of specific knockout rat phenotypes relevant to human disease will expand our understanding of the human condition and allow development of treatments to improve health and quality of life. In turn, accomplishment of efficient rat ES cell contribution to embryonic tissues and the germline requires improved knowledge of the nature of the starting population of rat ES cells and of the conditions required to maintain large proportions of such cells in the undifferentiated and pluripotent state.
Recent progress has been made through demonstration of germline transmission of wild-type and gene-targeted rat ES cells maintained under specialized culture conditions requiring chemical inhibitors [6] [7] [8] . However, in those studies, the culture conditions were not optimized to allow efficient germline transmission. Cell lines derived from rat blastocysts under conventional ES cell culture conditions, including culture with leukemia inhibitory factor (LIF), fetal bovine serum, and mouse embryonic fibroblasts (MEFs), either lose expression of the Pou5f1 pluripotency marker (also known as Oct4) within a few days [6, 9] or do not have the capacity to contribute to the germline [10] . The rat ES-like cells recently developed in our laboratory maintain high levels of POU5F1 expression over long-term culture, and, as recently demonstrated for the first time, can contribute to developing extraembryonic tissues in vivo [11] .
In the mouse, there are well-established cell culture models of lineage-restricted progenitors representing the early lineages of the embryo. These are ES cells, XEN (eXtraembryonic ENdoderm stem) cells, and trophoblast stem (TS) cells [12] . In contrast to the situation in the mouse, a clear understanding of early lineage segregation in the rat embryo is currently lacking. Recently, XEN-precursor (XEN-P) cells have been isolated from rat blastocysts [13, 14] . These cell lines, established by pooling multiple blastocyst outgrowths and culturing on MEFs or rat embryonic fibroblast cells in ES medium and LIF, appear to represent precursors of the extraembryonic lineages. However, they have been found to be Nanog-negative, and their capacity for in vitro differentiation into embryonic lineages has not yet been examined. It is not known whether a common precursor of epiblast, extraembryonic endoderm, and trophoblast exists, and the timing and nature of lineage selection have not yet been elucidated.
Here, the full developmental capacity of rat blastocystderived stem (RBS) cells was rigorously evaluated using a variety of approaches, combining multiple embryo injection and aggregation techniques with in vivo cell fate analysis, in vitro differentiation, and marker expression analysis.
MATERIALS AND METHODS

Cell Culture
The culture medium and rat ES medium, as well as the derivation, culture, and characterization of RBS cells, have been described previously [11, 15] . Briefly, RBS cell cultures were initiated from individual Embryonic Day (E) 4.5 blastocysts using flame-pulled Pasteur pipettes to selectively isolate the 
0 ; a nd r e v er s e p ri me r , 5 0 -GTTGTTGCCCTCATCTCTCTC-3 0 ; Ta ¼ 60; Gata4 forward primer, 5 0 -GCAGCAGCAGCAGTGAAGAGA-3 0 ; and reverse primer, 5
0 ; a n d r e v e r s e p r i m e r , 5 0 -AACTCTTGCCTCGTCCACTC-3 0 ; Ta ¼ 57; Nodal forward primer, 5 0 -GCAGACATCATCCGCAGCCT-3 0 ; and reverse primer, 5 0 -GTAGATGATC CAGGAGCCCC-3 0 ; Ta ¼ 57; Gata6 forward primer, 5 0 -AACGGGACGTAC CACCACCA-3 0 ; and reverse primer, 5 0 -GCACAGGACAATCCAAGCCG-3 0 ; Ta ¼ 57; and Eomes forward primer, 5 0 -CCACCGCCACCAAACTGAGATG-3 0 ; and reverse primer, 5 0 -CAGTATTAGGAGACTCTGGGTGAA-3 0 ; Ta ¼ 57. Genomic DNA was isolated and analyzed as described previously [11] , with the exception that PCR products were subjected to electrophoresis on agarose gels ranging between 1% and 2%.
Immunofluorescence and Flow Cytometry
RBS and EB cells were grown on Lab-Tek II CC2 chamber slides (Nalge Nunc International) and fixed with methanol at À208C for 5 min. Cells were washed twice with PBS and twice with 0.05% Tween-PBS (TPBS) for 5 min at room temperature and permeabilized with 0.1% Triton X-100-PBS for 10 min at room temperature. Then, cells were washed twice with TPBS for 5 min at room temperature, blocked with 4% normal goat serum (NGS)-PBS for 60 min at room temperature, and incubated with primary antibody diluted in 4% NGS-PBS overnight at 48C. Finally, cells were washed three times with TPBS for 10 min at room temperature, incubated with secondary antibody diluted in 4% NGS-PBS for 90 min at 48C, washed three times with TPBS for 10 min at room temperature, and mounted with 4 0 ,6-diamidino-2-phenylindole (DAPI) SlowFade Gold mounting medium (Invitrogen) and a coverslip prior to image acquisition. For negative controls, cells were incubated with corresponding isotype antibodies when available, instead of primary antibodies. Images were acquired using an Olympus FV1000 laser scanning confocal microscope (Olympus Canada, Markham, ON, Canada). Image acquisition and export as tagged image file format (TIFF) files were conducted using Olympus Fluoview FV10-ASW software. Antibodies, dilutions, and sources used were as follows: POU5F1 (1:50 dilution; Santa Cruz Biotechnology, Santa Cruz, CA); NANOG (1:150 dilution; ReproCell, Tokyo, Japan); NESTIN (1:100 dilution; Chemicon International, Temecula, CA); SOX1 (1:100 dilution; R&D Systems, Minneapolis, MN); TUBB3 (also known as betaIII-tubulin) (1/25 dilution; Chemicon); SOX17 (1:25 dilution; Santa Cruz Biotechnology); and brachyury (1:25 dilution; Santa Cruz Biotechnology). Alexa-fluor (Santa Cruz Biotechnology) secondary antibodies were used at a dilution of 1:1000. For fluorescence-activated cell sorting (FACS) analysis, the above-described protocol was used, with the exception that RBS and EB cells were grown on tissue culture-treated dishes, fixed with methanol at À208C overnight, centrifuged at 1000 3 g, and incubated with secondary antibody for 45 min at 48C. Antibodies, dilutions, and sources were as follows: NESTIN (1:50 dilution); SOX1 (1:50 dilution); SOX17 (1:50 dilution); brachyury (1:50 dilution); NANOG (1:50 dilution; Chemicon); SOX2 (1:50 dilution; Chemicon); and POU5F1 (1:50 dilution). FACS analysis was carried out with a FACSVantage SE (Becton Dickinson, Mississauga, ON). Gates were set relative to isotype controls. Collected data were analyzed using Cellquest Pro software (Becton Dickinson).
Animals, Embryos, and Procedures
All procedures using animals were conducted according to protocols approved by the institutional animal care and use committee in accordance with Canadian Council on Animal Care regulations. Rats of Sprague-Dawley (SD), Fischer (F344), and Brown Norway (BN) strains were purchased from Charles River Canada (St.-Constant, QC). Wistar-TgNCAG-GFP184Ys rats (RRRC line 259; Wistar Rat Resource and Research Center, Columbia, MO) were used for diploid (2n) and tetraploid (4n) aggregation experiments. Host embryos were obtained by mating SD/F344 females with F344 males. The presence of spermatozoa in vaginal smears at noon the day following copulation was taken as E0.5 of gestation. Blastocyst injections and embryo transfers were carried out as described previously [11] . Embryo aggregation procedures were adapted from the mouse and from earlier studies of rat embryos [16, 17] , with the exception that the culture medium for embryo culture and aggregation was mR1ECM [18] . Briefly, the zonae pellucidae of eight-cell-stage preimplantation embryos were removed by brief exposure, i.e., 15-to 30-sec, to acidic Tyrode solution, followed by washing in mR1ECM medium, and single denuded embryos were co-cultured with RBS cells in aggregation microwells. The 4n embryos were generated as described previously [16] . RBS cells between passage numbers 7 and 48 were used for embryo aggregation and injection experiments.
Immunohistochemistry
Immunohistochemistry was conducted according to the protocol described by Desmarais and colleagues [19] , with the following modifications: a primary rabbit polyclonal antibody recognizing green fluorescent protein (GFP) and its variants was used at 1:10 dilution (Clontech, Palo Alto, CA). A biotinylated anti-rabbit immunoglobulin G secondary antibody that recognizes heavy and light chains (1 lg/ml; Vector Laboratories, Burlingame, CA) was used to detect GFP and EYFP proteins. No signal was obtained when both primary and secondary antibodies were tested together on wild-type tissues. Negative control sections were submitted to the same procedures, except that the first antibody was replaced with 10% NGS-TPBS.
Statistical Analysis
The chi-square exact test was used to analyze the data in Table 1 , using SAS software (Cary, NC).
RESULTS
RBS Cells Express Multiple Pluripotency Markers
We previously reported the isolation and in vitro and in vivo characterization of novel RBS cells that maintain Pou5f1 mRNA and protein expression after multiple in vitro manipulations and long-term culture [11] . These cells possess a normal 2n karyotype and are also positive for alkaline phosphatase and stage-specific embryonic antigen-1 [11] . In an attempt to expand on these results and investigate the pluripotent marker status of these cells, RT-PCR was used to assess the presence of transcripts known to be expressed in both mouse and human ES cells. Transcripts coding for numerous pluripotency markers including Pou5f1, Nanog, Sox2, Rex1 (also known as Zfp42), Tdgf1, and Gdf3 were found to be expressed in undifferentiated RBS cells (Fig. 1A) . Positive control cDNA from rat blastocysts was used to ensure suitability of the primers for amplifying rat transcripts. Using immunofluorescence, we found that expression of POU5F1 RAT EMBRYONIC AND EXTRAEMBRYONIC STEM CELLS protein was localized to the nucleus, as expected, while no signal was detected using the isotype control (Fig. 1B) . In a similar fashion, NANOG protein was also found to localize to the nucleus (Fig. 1C) . Together, these results confirmed the ESlike identity of our cells with respect to pluripotent marker expression.
Cell Fate Analysis Reveals In Vivo Multipotency of RBS Cells via Contribution to Multiple Extraembryonic Lineages Following Blastocyst Injection and Embryo Transfer
In vivo assessment of developmental capacity is essential to determine the functionality and lineage restriction of cells derived from early embryos. In our previous studies, we demonstrated that RBS cells contribute in vivo to developing extraembryonic tissues after blastocyst injection and embryo transfer; however, it was not shown which tissues specifically displayed RBS cell contribution [11] . An enhanced yellow fluorescent protein (EYFP) transgene was used as an intracellular marker to track the cell fate and developmental potential of RBS cells in vivo, to better determine their exact tissue distribution. To determine whether RBS cells were able to contribute to multiple extraembryonic and embryonic tissues and the germline of rats in vivo, this method of blastocyst injection followed by embryo transfer was performed, rather than teratoma formation. The majority (over 58.6%) of transfected cells were shown to express the transgene ( Fig.  2A) . A total of 51 2n rat blastocysts were injected with transgenic cells and transferred to the uteri of pseudopregnant recipients. The injected cells were seen to fluoresce brightly after blastocyst injection (Fig. 2B) , indicating the suitability of the transgene for tracking cell fate in vivo. At E17.5, uteri were 1130 recovered, and implantation sites and fetuses were counted and analyzed. A total of 31 implantation sites were found (61% of transferred embryos), and 11 fetuses were recovered (37% of implanted embryos), indicating successful embryo transfer procedures. A PCR assay of genomic DNA isolated separately from embryonic and extraembryonic tissues of recovered fetuses was used to detect the presence of the transgene in these tissues (Fig. 2C) . Using this assay, we found extraembryonic tissues of six fetuses that contained the transgene, indicating that the RBS cells had contributed to these tissues during development, validating the results of our previous study [11] . Importantly, this time, to determine the cell fate of RAT EMBRYONIC AND EXTRAEMBRYONIC STEM CELLS the injected transgenic RBS cells in vivo, their precise tissue distribution was tracked using immunohistochemistry. Duplicate samples of extraembryonic tissues found to be positive for the EYFP transgene by PCR were subjected to immunohistochemistry for detection of EYFP protein in tissue sections. As can be seen in Figure 2D , EYFP-positive cells were found in multiple developmentally distinct extraembryonic lineages, notably in trophoblast, visceral yolk sac, and parietal yolk sac tissues, clearly demonstrating that these cells are multipotent and can contribute to functional and developmentally distinct extraembryonic tissues during development. Despite this wide developmental potential, however, their in vivo contribution was still restricted to extraembryonic tissues and was not found in embryonic tissues.
Embryo Aggregation and Transfer Assays Also Reveal In Vivo Multipotency of RBS Cells
We surmised that the host blastocyst stage embryo restricts the developmental potential of RBS cells by hampering their physical integration into the ICM. Our hypothesis was that RBS cells could contribute to a wider range of tissues if host embryos at an earlier developmental stage than the blastocyst were used to carry out the in vivo developmental capacity assays. To test this hypothesis, we adapted an embryo aggregation assay frequently used in mice to determine the developmental potential of ES cells and to generate embryonic chimeras [20] . The 2n eight-cell-stage rat embryos were collected and used to generate aggregates with transgenic RBS cells, as shown in Figure 3A . The 4n embryos were successfully generated by electrofusion of two-cell-stage embryos (Fig. 3B, left panel) at a highly efficient rate of 97% (137/141). Confirmation of complete fusion was carried out by visual observation of blastomere membrane unification 30 min later (Fig. 3B, right panel) , and all unfused two-cellstage embryos were set aside from fused embryos at this time.
After 48 h of in vitro culture to the four-cell stage, pairs of 4n embryos were then used to generate aggregates with RBS cells by co-culture, as was done for 2n aggregates (Fig. 3A) . To determine the capacity of RBS cells to contribute to the early lineages of the embryo, their cell fate in chimeric blastocysts following aggregation was observed by fluorescence microscopy. Thus, after 36 h of in vitro culture, the resulting blastocysts were examined to determine the contribution of fluorescent RBS cells to various compartments. Transgeneexpressing cells were found throughout resulting blastocysts, illustrating their capacity to contribute to both the ICM and trophectoderm (TE) compartments in chimeric blastocysts (Fig.  3C) .
The in vitro culture system proved to be very efficient, as most of the control 2n embryos successfully reached the morula/blastocyst stage (Table 1 ). In addition, no significant differences were found in terms of in vitro development rate among the control (96%), 2n aggregation (96%), and 4n aggregation (100%) groups (P ¼ 0.30). Embryos from all three groups were transferred to the uteri of pseudopregnant dams to assess their developmental capacity. At E14, uteri were recovered, and implantation sites and fetuses were counted. No significant differences were found in the implantation rates (control: 44%, 2n aggregation: 47%, 4n aggregation: 46%) nor in the in vivo development rates of fetuses to midgestation (control: 14%, 2n aggregation: 4%, 4n aggregation: 0%) (P ¼ 1 and P ¼ 0.17, respectively [ Table 1 ]). The results from both in vitro and in vivo development suggest that the presence of RBS cells in aggregates did not adversely affect either implantation rate or in vivo development. As in the blastocyst injection experiment, a PCR assay of genomic DNA was carried out to detect the transgene in extraembryonic versus embryonic tissues (Fig. 4A) . In the 2n aggregation group, the transgene was once again detected in the extraembryonic tissues but not in the embryonic tissues ( Fig. 4A and Table 1 ). Interestingly, in the 4n aggregation group, although no fetuses were recovered, tissues similar in appearance to teratomas were found to have developed in the uteri of two females (Table 1) . During dissection, it was noted that these teratoma-like tissues contained cartilaginous structures. Furthermore, the transgene was detected by PCR in these tissues, and upon immunohistochemical staining, transgene-positive cells were found to have contributed to a wide variety of cell types, including tissues resembling endothelium and cartilage (Fig. 4 , A and C, and data not shown). More precise tissue distribution of the 1132 transgenic RBS cells in the 2n aggregation group was then determined using immunohistochemistry (Fig. 4B) . RBS cells were found to have contributed to trophoblast giant cells and to tissues of the parietal yolk sac (Fig. 4B, left panel) , visceral yolk sac (Fig. 4B, central panel) , and labyrinthine zone of the placenta (Fig. 4B, right panel) , suggesting early and persistent contribution of RBS cells to the primitive endoderm and TE lineages of the blastocyst following aggregation. Together, these results clearly demonstrate the in vivo multipotency of our RBS cells by the use of embryo aggregation methods and confirm similar results obtained using blastocyst injections (Fig. 2, C and D) . Moreover, they demonstrate for the first time that the embryo/stem cell aggregation method described here for the rat is suitable to generate viable 2n embryo aggregates that can implant and develop normally to midgestation. This is a valuable new tool with which to track the in vivo cell fate and tissue contribution of RBS cells notably to the extraembryonic tissues.
RBS Cells Display Pluripotent Capacity via In Vitro Differentiation into the Three Primary Germ Layers of the Embryo Proper
We hypothesized that the bias of our RBS cells toward extraembryonic tissue contribution in vivo could be due to their intrinsic inability to differentiate into tissues of the three primary germ layers of the embryo proper. To test this hypothesis, the developmental capacity of RBS cells was evaluated using an in vitro assay of pluripotency, in vitro differentiation through embryoid body formation, in the prolonged absence of LIF and MEFs (Fig. 5A) [21] . The expression levels of ectoderm, endoderm, and mesoderm markers in the resulting differentiated cells were then analyzed. TUBB3, a neurectoderm marker, was found to be expressed in rat EB-derived cells, and important proportions of cells expressed the ectoderm markers NESTIN and SOX1 (Fig.  5B) . Endoderm markers including SOX17 and FOXA2 were also expressed, indicating a capacity for RBS cells to differentiate into this embryonic lineage in vitro (Fig. 5C) . Finally, mesoderm differentiation was also observed, with a large proportion of cells expressing T (brachyury), and multiple other mesodermal markers were also expressed, including Sparc, Gata4, and Runx2 (Fig. 5D) . Therefore, in addition to their in vivo multipotency, RBS cells were also able to robustly differentiate into derivatives of all three primary germ layers of the embryo in vitro, as demonstrated by flow cytometry, immunofluorescence and confocal microscopy, and RT-PCR. Taken together, these results suggest that RBS cells possess a much wider developmental potential than previously thought. Furthermore, it indicates that RBS cells are not biased intrinsically to give rise exclusively to extraembryonic tissues. 
Expression Profile of RBS Cells Before and After Differentiation Reveals Similarities to Mouse Epiblast Stem Cells and Human ES Cells
The intriguing inability of our cells to contribute to tissues of the embryo proper in vivo coupled with their capacity to robustly differentiate into derivatives of all three germ layers in vitro and their persistent tendency to contribute to extraembryonic tissues in vivo prompted us to investigate their nature in greater detail. Recent reports of mouse epiblast stem cells (mEpiSCs) suggested that, similar to RBS cells, these pluripotent cells cannot efficiently colonize tissues of the embryo proper following blastocyst injection or embryo aggregation and embryo transfer [22, 23] . These cells can also differentiate in vitro to all germ layers and can be induced to develop toward extraembryonic cell fates in vitro, pointing to similarities between mEpiSCs and RBS cells [23] . In addition, human ES (hES) cells are also known to differentiate into extraembryonic cell types in vitro [12, 24] . Incidentally, mEpiSCs and hES cells also share multiple characteristics including similar marker expression and are distinct from mouse ES cells [22, 23] . We therefore examined both undifferentiated RBS cells and EB-derived cells for expression of genes typically found in mEpiSC and hES cell cultures (Fig.  6A) . Surprisingly, genes expressed in both mEpiSCs and hES cells, including Nodal, Foxa2, Gata6, and Eomes, were found to be expressed not only in undifferentiated RBS cells but also in differentiated EB cells, showing similar marker expression among these mouse, human, and rat embryonic cell populations. These results, combined with a comparable pluripotent cell marker expression profile (Fig. 1) , suggest some level of similarity between ES cells derived from rat and human blastocysts and mEpiSCs derived from mouse epiblasts. It should be noted, however, that some of these markers are not exclusively expressed in the epiblast. In particular, the Gata6 gene is also a marker of primitive endoderm, the Foxa2 gene is associated with visceral endoderm, and the Eomes gene is a marker of TS cells.
RBS Cells Display Features of Heterogeneity While Maintaining Expression of Multiple Pluripotency Markers under Conditions Favoring Differentiation
Little is known about the specific culture requirements for maintenance of pluripotency in rat ES cells. To determine whether LIF signaling and MEFs are required for the maintenance of pluripotency markers in RBS cells, the expression levels of POU5F1, NANOG, and SOX2 proteins in undifferentiated clumps of RBS cells were compared to those in differentiated EB-derived cells by flow cytometry (Fig.  6B) . The majority (71.3%) of undifferentiated cells were found to be POU5F1-positive, whereas lower proportions were positive for NANOG (17.2%) and SOX2 (30.0%), raising the possibility of phenotypic heterogeneity within RBS cell cultures. In contrast, the proportion of cells expressing POU5F1 in the differentiated EB-derived cells was greatly reduced, with 8.6% of cells staining positive for this transcription factor. Surprisingly, the differentiated EB-derived cells continued to express POU5F1, NANOG, and SOX2 proteins after more than 45 days of culture in the absence of LIF and MEFs (four passages). These results suggest that RBS cells do not require LIF or MEFs to maintain expression of pluripotency markers, revealing another important difference from mouse ES cells and further similarity with mEpiSCs and hES cells.
DISCUSSION
In previous reports we suggested that RBS cells could be intermediate in phenotype between pluripotent epiblast and primitive endoderm [11, 15] . Here we provide evidence that RBS cells are capable of in vitro differentiation to embryonic germ layers and can contribute to primitive endoderm (and its descendants, visceral and parietal endoderm) and the TE lineage in vivo. Presently it is unknown whether some subset of cells within RBS cultures is a common precursor to both the embryonic and extraembryonic lineages or whether uncommitted as well as committed subtypes coexist. We show quantitatively, using intracellular staining and flow cytometry, that POU5F1, NANOG, and SOX2 are expressed to different degrees in populations of undifferentiated RBS cells. Indeed, when undifferentiated aggregates of RBS cells were analyzed by flow cytometry for expression of these three pluripotency markers, it was found that even though the majority of cells were positive for POU5F1, the proportions of cells staining positive for NANOG and SOX2 were much lower (Fig. 6B ). This suggests that there is a hierarchy of lineage marker expression in cells within RBS cell cultures, with POU5F1 being expressed in a majority of undifferentiated RBS cells, followed by SOX2 and finally NANOG. Importantly, these results suggest that RBS cells are phenotypically heterogeneous populations of cells, with various subsets differing in markers expressed and proportions of cells expressing those markers. Furthermore, this phenotypic heterogeneity varies according to their growth factor environment and differentiation state.
The fact that only a minority of cells express NANOG or SOX2 concomitant with epiblast marker expression suggests that there may be epiblast-like precursors present in this small NANOG-positive subset. This subset would then allow in vitro differentiation to the three embryonic germ layers. The presence of a pluripotent epiblast-like compartment within undifferentiated RBS aggregates undergoing constant selfrenewal, as well as yielding slightly more differentiated POU5F1-positive primitive endoderm-like cells, appears to be the best interpretation of the very stable phenotype of RBS cells observed under long-term in vitro culture conditions (more than 6.5 consecutive months of culture) [11] .
RBS cells resemble other pluripotent cell types in terms of their heterogeneous composition. In the literature, there is increasing evidence of heterogeneity within mouse and human ES cell cultures [25] [26] [27] [28] [29] [30] . Further analysis of isolated subsets of RBS cells will allow a more precise determination of possible differences in developmental potential of the various subsets. Perhaps the heterogeneous aggregates of RBS cells more accurately reflect the complex in vivo environment that rat ICM cells are subjected to in the blastocyst stage embryo, providing the appropriate cellular microenvironment to allow a small but fixed number of pluripotent cells, represented by the NANOG/SOX2-positive fraction, to survive over long-term culture. In this regard, our RBS cells provide a valuable in vitro model of rat epiblast differentiation and early rat embryo lineage segregation.
Similar cell lines from rat epiblast have been reported in terms of in vitro differentiation capacity, sensitivity to singlecell passaging, and growth factor dependence [23] . However, in addition to their different developmental origins, the flattened, compact colony morphology of these cells and their nearly homogeneous expression of pluripotency markers differs from that of RBS cells, and their in vivo developmental capacity is not yet known [23] . Rat XEN-P cells are also similar in their ability to contribute to extraembryonic endoderm; however, the absence of Nanog in these cells suggests that they may not contain an epiblast compartment [13, 14] . Consistent with this, no embryonic lineage contribution was reported.
Although others have reported the generation of 4n rat embryos [31, 32] and another group has attempted rat embryo/ ES aggregation [10] , no in vivo development has been reported so far. The developmental capacity of RBS cells was successfully analyzed using 2n and 4n embryo/RBS cell aggregation for the first time in the rat. RBS cells were found throughout the resulting blastocysts, including in the ICM, excluding the possibility that a lack of integration of RBS cells into the ICM could explain the absence of contribution to embryonic tissues later on during gestation. Furthermore, following embryo transfer, it was found that RBS cells had contributed to multiple developmentally distinct extraembryonic lineages. We have therefore demonstrated the validity and utility of a novel approach in the rat that simultaneously allows the evaluation of the role played by the host embryo developmental stage, the in vivo developmental capacity of RBS cells, and the subsequent tracking of cell fate and tissue contribution of RBS cells in vivo.
It is clear that the RBS cells described here express multiple markers of pluripotency ( Fig.1 and Fig. 6B ), similar to other pluripotent cell types such as mouse and human ES cells. Other groups have also recently derived rat ES or RBS cells that display pluripotent marker expression, and those reports have helped elucidate possible signaling pathways involved in pluripotency maintenance of rat ES cells [6, 7, 10, 33, 34] . In addition to pluripotency markers, lineage markers of epiblast, extraembryonic endoderm, and trophoblast were also detected in established undifferentiated RBS cell cultures. It is formally possible that some progenitors of primitive endoderm and trophoblast cells could have been carried over upon initial derivation of RBS cells. However, as in E3.5 mouse blastocysts, E4.5 rat ICMs have not yet developed a morphologically distinct primitive endoderm layer. In addition, the trophoblast Cdx2 marker could not be detected by RT-PCR in undifferentiated RBS cell cultures (data not shown), suggesting that bona fide trophoblasts and primitive endoderm cells were not present during the initial derivation of RBS cell cultures and that lineage markers of epiblast, extraembryonic endoderm, and trophoblast appeared after culture.
It seems likely that failure to select the appropriate minority of pluripotent cells within our RBS cultures explains the lack of embryonic contribution in vivo after reintroduction into host embryos, yet the ability to differentiate into all three embryonic germ layers was retained. Perhaps slightly more differentiated cells than pluripotent cells were selected from within undifferentiated RBS cultures. Although it is currently unknown whether the rat ES or RBS cells obtained by other groups are also phenotypically heterogeneous, it may be that their absence or low efficiency of contribution to embryonic tissues and particularly the germline in chimeras may be due to their heterogeneous composition and to selection of slightly less pluripotent cells within their populations before reintroduction into embryos [6, 7, 10] . It is also possible that even though the selected RBS cells described herein had integrated into the ICM, perhaps they had not yet had time to segregate into primitive endoderm and early epiblast components at the time they were examined and that the RBS cells were subsequently excluded from the epiblast and resultant embryonic tissues [35] .
The role of signaling pathways involved in maintenance of pluripotency in RBS cells is currently unclear. Upon in vitro differentiation of RBS cells into EB-derived cells and following prolonged culture in the absence of LIF and MEFs, the expression of pluripotency and epiblast stem cell markers was not abolished. This points to important differences in signaling pathways involved in pluripotency maintenance in RBS cells compared to those in mouse ES cells and reveals further similarities to human ES cells and mEpiSCs, which require fibroblast growth factor and activin rather than LIF signaling to self-renew [12, 22, 23, 36] . The modest increase in the NANOG-positive fraction of cells in EB cultures could indicate that RBS cells are more similar to human ES cells in terms of their growth factor requirements. Our results open a door to deciphering the role of signaling pathways involved in pluripotency maintenance of RBS cells. An interesting approach would be to evaluate whether RBS cells can be reprogrammed by the growth factor environment to full pluripotency, as has been shown recently in the mouse [37] .
In conclusion, our results provide new insight into the nature of RBS cell cultures and early rat embryo lineage selection by demonstrating that they are heterogeneous, i.e., they are composed of precursors of embryonic as well as extraembryonic lineages. This provides important clues to why embryonic and germline contributions of rat ES cells have been so difficult to achieve. The knowledge gained through this study has important implications for the elucidation of the precise mechanisms governing RBS cell pluripotency and lineage selection. It will accelerate our understanding of culture conditions required to favor differentiation to embryonic and extraembryonic lineages and to obtain and maintain undifferentiated pluripotent rat ES cells that are able to efficiently colonize not only embryonic tissues but also the germline, a prerequisite to the generation of knockout rats.
